Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-01-01 @ 7:33 AM
Study NCT ID:
NCT00293332
Status:
TERMINATED
Last Update Posted:
2011-02-09
First Post:
2006-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Sponsor:
University of California, San Francisco
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000455640
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sarita Dubey, M.D.
Old Organization:
UCSF
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |